Teva Pharmaceutical Industries Ltd (TEVJF) — 10-K Filings
All 10-K filings from Teva Pharmaceutical Industries Ltd. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Teva's Goodwill Hits $29.55B, $500M Anti-TL1A Deal
— Feb 5, 2025 Risk: medium
Teva Pharmaceutical Industries Ltd. reported cumulative goodwill impairment of approximately $29.55 billion as of December 31, 2024, an increase from $28.3 bill -
Teva Pharmaceuticals Files 2023 Annual Report on Form 10-K
— Feb 12, 2024 Risk: medium
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF) filed a Annual Report (10-K) with the SEC on February 12, 2024. Teva reported "Other revenues" in 2023 primarily from
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX